FAKTOR OPTIONSSCHEIN - BIOMERIEUX Share Price

Certificat

DE000GG61MA6

Market Closed - BOERSE MUENCHEN 11:56:45 07/06/2024 pm IST
14.11 EUR +15.85% Intraday chart for FAKTOR OPTIONSSCHEIN - BIOMERIEUX
Current month+70.41%
1 month+27.46%
Date Price Change
07/24/07 14.11 +15.85%
06/24/06 12.18 -5.65%
05/24/05 12.91 +11.58%
04/24/04 11.57 +0.52%
03/24/03 11.51 +39.01%

Real-time BOERSE MUENCHEN

Last update June 07, 2024 at 11:56 pm IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying BIOMÉRIEUX
Issuer Goldman Sachs
WKN GG61MA
ISINDE000GG61MA6
Date issued 11/04/2024
Strike 101
Maturity Unlimited
Parity 0.51 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 24.09
Lowest since issue 6.54
Spread 7
Spread %35.57%

Company Profile

bioMérieux designs, develops, produces, and sells systems used in clinical practice to diagnose infectious diseases (including HIV, tuberculosis, and respiratory infections), cancers, and cardiovascular pathologies based on a biological sample (blood, saliva, urine, etc.). Net sales break down by sector of application as follows: - medical applications (84.4%): in industry, microbiological testing of samples from finished products, materials during the manufacturing process, or the environment, primarily in the food-processing, pharmaceutical, and cosmetics sectors; - industrial applications (15.6%). The group's diagnostic systems consist of three elements with related services: reagents, instruments (or platforms or analyzers), software, and services. Net sales are distributed geographically as follows: Europe/Middle East/Africa (32.4%), North America (44.1), Asia/Pacific (17.3%) and Latin America (6.2%).
Sector
-
More about the company

Ratings for bioMérieux

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: bioMérieux

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
93.8 EUR
Average target price
113.5 EUR
Spread / Average Target
+20.98%
Consensus